| 注册
首页|期刊导航|中国药业|文拉法辛和氟西汀治疗抑郁症患者的比较研究

文拉法辛和氟西汀治疗抑郁症患者的比较研究

方华红 祝岱军

中国药业2012,Vol.21Issue(5):57-58,2.
中国药业2012,Vol.21Issue(5):57-58,2.

文拉法辛和氟西汀治疗抑郁症患者的比较研究

Comparative Study on Venlafaxine and Fluoxetine in Treatment of Patients with Depression

方华红 1祝岱军1

作者信息

  • 1. 浙江省岱山县第一人民医院,浙江舟山,316200
  • 折叠

摘要

Abstract

Objective To comparatively study the efficacy and safety of venlafaxine and fluoxetine in the treatment of the patients with depression. Methods According to the Category and Diagnostic Criteria of Mental Disorder of China, third edition(CCMD - 3), 110 cases of depression were randomly divided into two groups, venlafaxine group (n = 30) and the fluoxetine group (ft = 80). The efficacy was assessed using the Hamilton Depression Scale (HAMD). The safety and adverse reactions were assessed by the Treatment Emergent Symptom Scale(TESS). Results The excellent effective rate and the effective rate were 76.67% and 93.33% in the venlafaxine group, and 65.00% and 88.75% in the fluoxetine group without statistical difference between them( P > 0. 05). Conclusion Venlafaxine is safe and effective to treat depression, the adverse reactions and the curative efficacy have no significant difference with fluoxetine.

关键词

文拉法辛/氟西汀/抑郁症/疗效

Key words

venlafaxine/ fluoxetine/ depression/ efficacy

分类

医药卫生

引用本文复制引用

方华红,祝岱军..文拉法辛和氟西汀治疗抑郁症患者的比较研究[J].中国药业,2012,21(5):57-58,2.

中国药业

OACSTPCD

1006-4931

访问量0
|
下载量0
段落导航相关论文